Becton, Dickinson and Company (BDX) Financials

BDX Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 50.8 billion 26.7 billion
Dec. 31, 2025 54.8 billion 29.6 billion
Sept. 30, 2025 55.3 billion 29.9 billion
June 30, 2025 54.9 billion 29.4 billion

BDX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 546.0 million ?
Dec. 31, 2025 549.0 million 91.0 million
Sept. 30, 2025 1.0 billion 55.0 million
June 30, 2025 1.0 billion -239.0 million

BDX Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -310.0 million
Dec. 31, 2025 382.0 million
Sept. 30, 2025 493.0 million
June 30, 2025 552.0 million

BDX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 816.0 million 14.7 billion -
Dec. 31, 2025 1.0 billion 16.9 billion -
Sept. 30, 2025 859.0 million 17.6 billion -
June 30, 2025 757.0 million 17.5 billion -

BDX Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 280.6 million
Dec. 31, 2025 285.1 million
Sept. 30, 2025 287.1 million
June 30, 2025 288.7 million

BDX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 125.0 million 249.0 million 1.2 billion -
Dec. 31, 2025 108.0 million 318.0 million 1.4 billion -
Sept. 30, 2025 352.0 million 322.0 million 1.4 billion -
June 30, 2025 174.0 million 297.0 million 1.3 billion -

BDX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 4.7 billion 2.6 billion
Dec. 31, 2025 5.3 billion 2.9 billion
Sept. 30, 2025 5.9 billion 3.1 billion
June 30, 2025 5.5 billion 2.9 billion

BDX Revenue by Segment

Graph available only for paid members. Upgrade to see it.

BDX

List: Champions

Price: $151.16

52 week price:
126.09
187.35

Dividend Yield: 2.83%

5-year range yield:
1.02%
2.83%

Forward Dividend Yield: 2.81%

Payout Ratio: 76.31%

Payout Ratio Range:
-1991.67%
1230.00%

Dividend Per Share: 4.20 USD

Earnings Per Share: 5.72 USD

P/E Ratio: 25.21

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 2.1 million

Ebitda: 554.0 million

Market Capitalization: 39.7 billion

Average Dividend Frequency: 4

Years Paying Dividends: 44

DGR3: 6.43%

DGR5: 5.86%

DGR10: 5.96%

DGR20: 9.51%

Links: